loader2
Partner With Us NRI

Astrazeneca Pharma India Ltd share Price Today

Company details

5,068.60
5,296.00
3,125.00
7,220.95
6M Return 7.06%
1Y Return 63.80%
Mkt Cap.(Cr) 13,148.88
Volume 9,720
Div Yield 0.30%
OI
-
OI Chg %
-
Volume 9,720

Invest in Market with Confidence: High performance strike rate of over 72%

Trade, sell, withdraw – all in minutes!
icon 27 Years

of legacy

icon 4.4 Star

App Rating

icon 1 Crore +

Customers

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number

Astrazeneca Pharma India Ltd shares SWOT Analysis

Strengths (5)

  • Strong Annual EPS Growth
  • Company with No Debt
  • Book Value per share Improving for last 2 years

Weakness (3)

  • Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
  • Declining profits every quarter for the past 2 quarters
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (0)

Data not found

Threats (2)

  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 5,347.5
R2 5,435.5
R3 5,574.9
Pivot

5,208.05

S1 5,120.1
S2 4,980.7
S3 4,892.7
EMA SMA
5,299.3
5,340.7
5,301.3
4,976.2
5,309.3
5,280.0
5,549.6
4,986.7
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
ISHARES CORE MSCI EMERGING MARKETS ETF Block Purchase 2022-09-19 3152.55 74097 BSE
ISHARES MSCI INDIA SMALL-CAP ETF Block Purchase 2022-09-19 3152.55 6542 BSE
ISHARES CORE EMERGING MARKETS MAURITIUS CO Block Sell 2022-09-19 3152.55 74097 BSE
Name Category Shares
AstraZeneca Pharmaceuticals AB PROMOTER 75%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Astrazeneca Pharma India Ltd Stocks COMPARISON

Financials( in Cr) Astrazeneca Pharma India Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 5,259.55 1,506.55 1,339.55 3,793.50 982.15
% Change 2.47 0.80 -1.42 0.09 1.44
Mcap Cr 13,148.88 3,61,471.81 1,08,150.85 1,00,705.67 98,827.27
Revenue TTM Cr 1,002.97 43,885.68 22,753.12 7,767.51 17,237.40
Net Profit TTM Cr 99.29 8,560.84 2,835.49 1,823.38 1,997.30
PE TTM 82.42 38.52 25.40 72.78 29.65
1 Year Return 63.80 57.35 42.63 12.13 87.09
ROCE 30.47 16.79 17.79 19.30 16.25
ROE 22.95 16.46 12.82 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 588.69 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 40,292.52 -39,101.37
LAST 3M 97,195.39 -16,897.62
LAST 6M 1,59,485.99 61,690.63
LAST 12M 2,49,857.63 1,46,087.29

Astrazeneca Pharma India Ltd Information

Stock PE (TTM)
82.42
Promoter Holding
75%
Book Value
261.986
ROCE
30.47%
ROE
22.95%
Registered Address

Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road, Bangalore, Karnataka, 560045

Tel : 91-080-67748000
Email : comp.secy:astrazeneca.com
Website : http://www.astrazeneca.in
Registrar

Alpha Systems Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 506820
NSE Code : ASTRAZEN
Book Closure Date (Month) :
BSE Group : A
ISIN : INE203A01020

FAQ’s on Astrazeneca Pharma India Ltd Shares

You can buy Astrazeneca Pharma India Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Astrazeneca Pharma India Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 10, 2024 03:59 PM the closing price of Astrazeneca Pharma India Ltd was Rs.5,259.55.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of May 10, 2024 03:59 PM, the market cap of Astrazeneca Pharma India Ltd stood at Rs. 13,148.88.

The latest PE ratio of Astrazeneca Pharma India Ltd as of May 10, 2024 03:59 PM is 82.42

The latest PB ratio of Astrazeneca Pharma India Ltd as of May 10, 2024 03:59 PM is 0.05

The 52-week high of Astrazeneca Pharma India Ltd share price is Rs. 7,220.95 while the 52-week low is Rs. 3,125.00

According to analyst recommendations, Astrazeneca Pharma India Ltd Share has a "" rating for the long term.

Download App

Download Our App

Play Store App Store
market app

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number